Proto Labs, Inc. $PRLB Shares Sold by New York State Teachers Retirement System

Posted by Francis Steltz on Jul 14th, 2026

New York State Teachers Retirement System cut its stake in Proto Labs, Inc. (NYSE:PRLB – Free Report) by 50.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,536 shares of the industrial products company’s stock after selling 11,952 shares during the period. New York State Teachers Retirement System’s holdings in Proto Labs were worth $658,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Royal Bank of Canada increased its position in shares of Proto Labs by 51.3% during the first quarter. Royal Bank of Canada now owns 6,510 shares of the industrial products company’s stock worth $228,000 after purchasing an additional 2,207 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of Proto Labs by 3.3% in the 1st quarter. AQR Capital Management LLC now owns 63,871 shares of the industrial products company’s stock valued at $2,238,000 after purchasing an additional 2,040 shares during the period. NewEdge Advisors LLC boosted its position in shares of Proto Labs by 7,380.0% in the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock valued at $26,000 after purchasing an additional 738 shares during the period. JPMorgan Chase & Co. grew its stake in Proto Labs by 68.8% during the 2nd quarter. JPMorgan Chase & Co. now owns 21,756 shares of the industrial products company’s stock worth $871,000 after buying an additional 8,864 shares during the last quarter. Finally, Hsbc Holdings PLC acquired a new position in Proto Labs during the second quarter worth approximately $480,000. Institutional investors and hedge funds own 84.54% of the company’s stock.

Proto Labs Stock Up 0.3%

Shares of Proto Labs stock opened at $74.60 on Tuesday. Proto Labs, Inc. has a 52-week low of $38.48 and a 52-week high of $83.15. The company’s 50-day simple moving average is $75.17 and its 200-day simple moving average is $64.39. The firm has a market cap of $1.77 billion, a price-to-earnings ratio of 70.37 and a beta of 1.38.

Proto Labs (NYSE:PRLB – Get Free Report) last announced its quarterly earnings data on Friday, May 1st. The industrial products company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. The firm had revenue of $139.34 million during the quarter, compared to the consensus estimate of $135.31 million. Proto Labs had a net margin of 4.71% and a return on equity of 4.15%. The firm’s revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.33 earnings per share. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. Equities research analysts anticipate that Proto Labs, Inc. will post 1.37 EPS for the current year.

Insider Buying and Selling

In other news, insider Michael R. Kenison sold 16,030 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $69.49, for a total value of $1,113,924.70. Following the completion of the sale, the insider directly owned 18,683 shares of the company’s stock, valued at $1,298,281.67. This trade represents a 46.18% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sven Wehrwein sold 2,000 shares of Proto Labs stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total value of $154,560.00. Following the completion of the sale, the director owned 32,505 shares in the company, valued at approximately $2,511,986.40. This trade represents a 5.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 25,663 shares of company stock valued at $1,804,727. Company insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

PRLB has been the subject of a number of research reports. Wall Street Zen upgraded Proto Labs from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Weiss Ratings lowered shares of Proto Labs from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, June 29th. Zacks Research cut shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a report on Friday, July 3rd. Finally, Benchmark upped their price target on shares of Proto Labs from $70.00 to $91.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Proto Labs presently has an average rating of “Moderate Buy” and a consensus target price of $65.33.

Get Our Latest Report on PRLB

Proto Labs Profile

(Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.